LIK066, a Dual SGLT1/2 Inhibitor, Reduces Weight and Improves Multiple Incretin Hormones in Clinical Proof-of-Concept Studies in Obese Patients With or Without Diabetes
2020 ◽
Vol 08
(05)
◽
pp. E607-E610
◽
1989 ◽
Vol 47
◽
pp. 668-669
Keyword(s):
Keyword(s):